The role of IL-10 in immune regulation during M. tuberculosis infection

During gaseous exchange the lungs are exposed to a vast variety of pathogens, allergens, and innocuous particles. A feature of the lung immune response to lung-tropic aerosol-transmitted bacteria such as Mycobacterium tuberculosis (Mtb) is a balanced immune response that serves to restrict pathogen growth while not leading to host-mediated collateral damage of the delicate lung tissues. One immune-limiting mechanism is the inhibitory and anti-inflammatory cytokine interleukin (IL)-10. IL-10 is made by many hematopoietic cells and a major role is to suppress macrophage and dendritic cell (DC) functions, which are required for the capture, control, and initiation of immune responses to pathogens such as Mtb. Here, we review the role of IL-10 on bacterial control during the course of Mtb infection, from early innate to adaptive immune responses. We propose that IL-10 is linked with the ability of Mtb to evade immune responses and mediate long-term infections in the lung.

[1]  Margarida Saraiva,et al.  Interleukin-10 Production by Th1 Cells Requires Interleukin-12-Induced STAT4 Transcription Factor and ERK MAP Kinase Activation by High Antigen Dose , 2009, Immunity.

[2]  P. D. Hart,et al.  RESPONSE OF CULTURED MACROPHAGES TO MYCOBACTERIUM TUBERCULOSIS, WITH OBSERVATIONS ON FUSION OF LYSOSOMES WITH PHAGOSOMES , 1971, The Journal of experimental medicine.

[3]  J. Gerber,et al.  Reversing lipopolysaccharide toxicity by ligating the macrophage Fc gamma receptors. , 2001, Journal of immunology.

[4]  J. Sedgwick,et al.  Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection, which is not compensated for by lymphotoxin. , 1999, Journal of immunology.

[5]  R. North,et al.  The Relative Importance of T Cell Subsets in Immunity and Immunopathology of Airborne Mycobacterium tuberculosis Infection in Mice , 2001, The Journal of experimental medicine.

[6]  H. Bang,et al.  Tuberculosis Is Associated with a Down-Modulatory Lung Immune Response That Impairs Th1-Type Immunity1 , 2009, The Journal of Immunology.

[7]  Dinakar,et al.  T cell cytokine responses in persons with tuberculosis and human immunodeficiency virus infection. , 1994, The Journal of clinical investigation.

[8]  J. Ernst,et al.  Mycobacterium tuberculosis Infects Dendritic Cells with High Frequency and Impairs Their Function In Vivo1 , 2007, The Journal of Immunology.

[9]  S. Dorman,et al.  Interferon-gamma and interleukin-12 pathway defects and human disease. , 2000, Cytokine & growth factor reviews.

[10]  J. Blackwell,et al.  Interleukin-4 (IL-4) and IL-10 Collude in Vaccine Failure for Novel Exacerbatory Antigens in Murine Leishmania major Infection , 2005, Infection and Immunity.

[11]  J. Friedland,et al.  Regulation of IL-10 secretion after phagocytosis of Mycobacterium tuberculosis by human monocytic cells. , 2000, Cytokine.

[12]  D. Raoult,et al.  The two faces of interleukin 10 in human infectious diseases. , 2006, The Lancet. Infectious diseases.

[13]  R. Rojas,et al.  Regulation of human CD4(+) alphabeta T-cell-receptor-positive (TCR(+)) and gammadelta TCR(+) T-cell responses to Mycobacterium tuberculosis by interleukin-10 and transforming growth factor beta. , 1999, Infection and immunity.

[14]  F. Deist,et al.  Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. , 1998, Science.

[15]  Margarida Saraiva,et al.  The regulation of IL-10 production by immune cells , 2010, Nature Reviews Immunology.

[16]  Gisen Kim,et al.  Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis , 2009, Nature Immunology.

[17]  Richard A. Flavell,et al.  Conventional T-bet+Foxp3− Th1 cells are the major source of host-protective regulatory IL-10 during intracellular protozoan infection , 2007, The Journal of experimental medicine.

[18]  A. Yahagi,et al.  Suppressed induction of mycobacterial antigen-specific Th1-type CD4+ T cells in the lung after pulmonary mycobacterial infection. , 2010, International immunology.

[19]  M. Newport,et al.  Clinical features of dominant and recessive interferon gamma receptor 1 deficiencies. , 2004, Lancet.

[20]  W. Alexander,et al.  General Nature of the STAT3-Activated Anti-Inflammatory Response1 , 2006, The Journal of Immunology.

[21]  J. Flynn,et al.  Mice deficient in CD4 T cells have only transiently diminished levels of IFN-gamma, yet succumb to tuberculosis. , 1999, Journal of immunology.

[22]  C. Lowenstein,et al.  Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. , 1995, Immunity.

[23]  J. Kolls,et al.  Th17 cells and mucosal host defense. , 2007, Seminars in immunology.

[24]  J. F. Brown,et al.  Treatment with anti-interleukin-10 monoclonal antibody enhances early resistance to but impairs complete clearance of Listeria monocytogenes infection in mice , 1994, Infection and immunity.

[25]  I. Orme,et al.  In Vivo IL-10 Production Reactivates Chronic Pulmonary Tuberculosis in C57BL/6 Mice1 , 2002, The Journal of Immunology.

[26]  B. Ryffel,et al.  Increased resistance to mycobacterial infection in the absence of interleukin‐10 , 2000, Immunology.

[27]  S. Behar,et al.  In Vivo Depletion of CD11c+ Cells Delays the CD4+ T Cell Response to Mycobacterium tuberculosis and Exacerbates the Outcome of Infection1 , 2005, The Journal of Immunology.

[28]  R. Rojas,et al.  Regulation of Human CD4+ αβ T-Cell-Receptor-Positive (TCR+) and γδ TCR+ T-Cell Responses to Mycobacterium tuberculosis by Interleukin-10 and Transforming Growth Factor β , 1999, Infection and Immunity.

[29]  B. Musellim,et al.  Interleukin-10 and tumor necrosis factor-alpha gene polymorphisms in tuberculosis. , 2008, Journal of clinical immunology.

[30]  S. Swain,et al.  Interleukin 12p40 is required for dendritic cell migration and T cell priming after Mycobacterium tuberculosis infection , 2006, The Journal of experimental medicine.

[31]  J. Flynn,et al.  An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection , 1993, The Journal of experimental medicine.

[32]  J. Keane,et al.  Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. , 2001, The New England journal of medicine.

[33]  S. Ehlers,et al.  Autocrine IL-10 Induces Hallmarks of Alternative Activation in Macrophages and Suppresses Antituberculosis Effector Mechanisms without Compromising T Cell Immunity1 , 2009, The Journal of Immunology.

[34]  M. Newport,et al.  Interleukin-10, polymorphism in SLC11A1 (formerly NRAMP1), and susceptibility to tuberculosis. , 2002, The Journal of infectious diseases.

[35]  R. North Mice incapable of making IL‐4 or IL‐10 display normal resistance to infection with Mycobacterium tuberculosis , 1998, Clinical and experimental immunology.

[36]  R. Wood,et al.  Pulmonary tuberculosis in HIV infection: radiographic appearance is related to CD4+ T-lymphocyte count. , 1995, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[37]  I. Orme,et al.  Local pulmonary immunotherapy with siRNA targeting TGFβ1 enhances antimicrobial capacity in Mycobacterium tuberculosis infected mice. , 2011, Tuberculosis.

[38]  Y. Belkaid,et al.  CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity , 2002, Nature.

[39]  Ilkka Julkunen,et al.  Infection of Human Macrophages and Dendritic Cells with Mycobacterium tuberculosis Induces a Differential Cytokine Gene Expression That Modulates T Cell Response1 , 2001, The Journal of Immunology.

[40]  I. Orme,et al.  Interleukin 12 (IL-12) Is Crucial to the Development of Protective Immunity in Mice Intravenously Infected with Mycobacterium tuberculosis , 1997, The Journal of experimental medicine.

[41]  J. Casanova,et al.  Genetic dissection of immunity to mycobacteria: the human model. , 2002, Annual review of immunology.

[42]  B. Ryffel,et al.  Enhanced Immune Response in Mycobacterium bovis Bacille Calmette Guerin (BCG)-Infected IL-10-Deficient Mice , 2002, Clinical chemistry and laboratory medicine.

[43]  L. Groebe,et al.  Monocytes/macrophages and/or neutrophils are the target of IL‐10 in the LPS endotoxemia model , 2010, European journal of immunology.

[44]  S. Dorman,et al.  Mutation in the signal-transducing chain of the interferon-gamma receptor and susceptibility to mycobacterial infection. , 1998, The Journal of clinical investigation.

[45]  A. Pacheco,et al.  IFNG +874T/A, IL10 -1082G/A and TNF -308G/A polymorphisms in association with tuberculosis susceptibility: a meta-analysis study , 2008, Human Genetics.

[46]  L. García,et al.  Cytokine gene polymorphisms in Colombian patients with different clinical presentations of tuberculosis. , 2006, Tuberculosis.

[47]  A. Apt,et al.  Neutrophil Responses to Mycobacterium tuberculosis Infection in Genetically Susceptible and Resistant Mice , 2005, Infection and Immunity.

[48]  P. Linsley,et al.  Interleukin-10 downregulates Mycobacterium tuberculosis-induced Th1 responses and CTLA-4 expression , 1996, Infection and immunity.

[49]  S. Kaufmann,et al.  New insights into the function of granulomas in human tuberculosis , 2006, The Journal of pathology.

[50]  JoAnne L. Flynn,et al.  Effects of Tumor Necrosis Factor Alpha on Host Immune Response in Chronic Persistent Tuberculosis: Possible Role for Limiting Pathology , 2001, Infection and Immunity.

[51]  G. Cheng,et al.  Lipopolysaccharide-Mediated IL-10 Transcriptional Regulation Requires Sequential Induction of Type I IFNs and IL-27 in Macrophages , 2010, The Journal of Immunology.

[52]  J. Son,et al.  Polymorphisms of interleukin‐10 and tumour necrosis factor‐α genes are associated with newly diagnosed and recurrent pulmonary tuberculosis , 2007, Respirology.

[53]  Yu-Jin Jung,et al.  Increased interleukin‐10 expression is not responsible for failure of T helper 1 immunity to resolve airborne Mycobacterium tuberculosis infection in mice , 2003, Immunology.

[54]  Alan D. Roberts,et al.  ESAT-6-specific CD4 T cell responses to aerosol Mycobacterium tuberculosis infection are initiated in the mediastinal lymph nodes , 2008, Proceedings of the National Academy of Sciences.

[55]  J. Mudgett,et al.  Identification of nitric oxide synthase as a protective locus against tuberculosis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[56]  J. Blackwell,et al.  IL-10 from Regulatory T Cells Determines Vaccine Efficacy in Murine Leishmania major Infection1 , 2005, The Journal of Immunology.

[57]  A. Sher,et al.  IL-10 Is Required for Prevention of Necrosis in the Small Intestine and Mortality in Both Genetically Resistant BALB/c and Susceptible C57BL/6 Mice Following Peroral Infection with Toxoplasma gondii1 , 2000, The Journal of Immunology.

[58]  R. Young,et al.  T cell-derived IL-10 antagonizes macrophage function in mycobacterial infection. , 1997, Journal of immunology.

[59]  R. Appelberg,et al.  Blocking the Receptor for IL-10 Improves Antimycobacterial Chemotherapy and Vaccination1 , 2001, The Journal of Immunology.

[60]  B. Musellim,et al.  Interleukin-10 and Tumor Necrosis Factor-α Gene Polymorphisms in Tuberculosis , 2008, Journal of Clinical Immunology.

[61]  N. Reiling,et al.  MyDths and un-TOLLed truths: sensor, instructive and effector immunity to tuberculosis. , 2008, Immunology letters.

[62]  J. Gerber,et al.  Reversing Lipopolysaccharide Toxicity by Ligating the Macrophage Fcγ Receptors1 , 2001, The Journal of Immunology.

[63]  John Chan,et al.  What's good for the host is good for the bug. , 2005, Trends in microbiology.

[64]  D. Rennick,et al.  Endogenous Inhibition of Antimycobacterial Immunity by IL‐10 Varies between Mycobacterial Species , 2001, Scandinavian journal of immunology.

[65]  G. Köhler,et al.  Both innate and acquired immunity to Listeria monocytogenes infection are increased in IL-10-deficient mice. , 1997, Journal of immunology.

[66]  Steven M. Holland,et al.  Impairment of Mycobacterial But Not Viral Immunity by a Germline Human STAT1 Mutation , 2001, Science.

[67]  K. Takatsu,et al.  Pathogen-specific regulatory T cells delay the arrival of effector T cells in the lung during early tuberculosis , 2010, The Journal of experimental medicine.

[68]  G. Trinchieri,et al.  CD4+ T Cell Clones Producing both Interferon-γ and Interleukin-10 Predominate in Bronchoalveolar Lavages of Active Pulmonary Tuberculosis Patients , 1999 .

[69]  M. Newport,et al.  Polymorphism in the Interferon‐γ Receptor‐1 Gene and Susceptibility to Pulmonary Tuberculosis in The Gambia , 2003, Scandinavian journal of immunology.

[70]  D. Sacks,et al.  CD4+CD25−Foxp3− Th1 cells are the source of IL-10–mediated immune suppression in chronic cutaneous leishmaniasis , 2007, The Journal of experimental medicine.

[71]  C. Dye,et al.  Tuberculosis control in the era of HIV , 2005, Nature Reviews Immunology.

[72]  Xin Xu,et al.  Selective functional inhibition of JAK-3 is sufficient for efficacy in collagen-induced arthritis in mice. , 2010, Arthritis and rheumatism.

[73]  J. Ernst,et al.  Initiation of the adaptive immune response to Mycobacterium tuberculosis depends on antigen production in the local lymph node, not the lungs , 2008, The Journal of experimental medicine.

[74]  Alicia González,et al.  Interferon-gamma and interleukin-10 gene polymorphisms in pulmonary tuberculosis. , 2003, American journal of respiratory and critical care medicine.

[75]  I. Orme,et al.  Disseminated tuberculosis in interferon gamma gene-disrupted mice , 1993, The Journal of experimental medicine.

[76]  T. Geijtenbeek,et al.  Mycobacteria Target DC-SIGN to Suppress Dendritic Cell Function , 2003, The Journal of experimental medicine.

[77]  A. O’Garra,et al.  IL-10-producing and naturally occurring CD4+ Tregs: limiting collateral damage. , 2004, The Journal of clinical investigation.

[78]  S. Khader,et al.  IL-23 and IL-17 in tuberculosis. , 2008, Cytokine.

[79]  M. Reed,et al.  A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response , 2004, Nature.

[80]  J. Flynn,et al.  IL-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis infection. , 1995, Journal of immunology.

[81]  S. Akira,et al.  Macrophages and Myeloid Dendritic Cells, but Not Plasmacytoid Dendritic Cells, Produce IL-10 in Response to MyD88- and TRIF-Dependent TLR Signals, and TLR-Independent Signals1 , 2006, The Journal of Immunology.

[82]  I. Orme,et al.  The Hypervirulent Mycobacterium tuberculosis Strain HN878 Induces a Potent TH1 Response followed by Rapid Down-Regulation1 , 2007, The Journal of Immunology.

[83]  R. Appelberg,et al.  IL-10 Underlies Distinct Susceptibility of BALB/c and C57BL/6 Mice to Mycobacterium avium Infection and Influences Efficacy of Antibiotic Therapy1 , 2007, The Journal of Immunology.

[84]  Joseph Keane,et al.  Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent , 2001 .

[85]  N. Boéchat,et al.  Down-Modulation of Lung Immune Responses by Interleukin-10 and Transforming Growth Factor β (TGF-β) and Analysis of TGF-β Receptors I and II in Active Tuberculosis , 2004, Infection and Immunity.

[86]  A. Sher,et al.  Paralysis of dendritic cell IL-12 production by microbial products prevents infection-induced immunopathology. , 1999, Immunity.

[87]  H. Whittle,et al.  Assessment of the interleukin 1 gene cluster and other candidate gene polymorphisms in host susceptibility to tuberculosis. , 1998, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[88]  M. Newport,et al.  Clinical features of dominant and recessive interferon γ receptor 1 deficiencies , 2004, The Lancet.

[89]  R. Sartor,et al.  Resident Enteric Bacteria Are Necessary for Development of Spontaneous Colitis and Immune System Activation in Interleukin-10-Deficient Mice , 1998, Infection and Immunity.

[90]  R. Coffman,et al.  Interleukin-10 (IL-10) in Experimental Visceral Leishmaniasis and IL-10 Receptor Blockade as Immunotherapy , 2002, Infection and Immunity.

[91]  A. Sher,et al.  In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha. , 1996, Journal of immunology.

[92]  J. Wain,et al.  A deletion defining a common Asian lineage of Mycobacterium tuberculosis associates with immune subversion , 2006, Proceedings of the National Academy of Sciences.

[93]  A. Sher,et al.  Cutting Edge: Caspase-1 Independent IL-1β Production Is Critical for Host Resistance to Mycobacterium tuberculosis and Does Not Require TLR Signaling In Vivo , 2010, The Journal of Immunology.

[94]  J. Casanova,et al.  Inborn errors of interferon (IFN)‐mediated immunity in humans: insights into the respective roles of IFN‐α/β, IFN‐γ, and IFN‐λ in host defense , 2008, Immunological reviews.

[95]  L. Bermudez,et al.  Infection with Mycobacterium avium induces production of interleukin-10 (IL-10), and administration of anti-IL-10 antibody is associated with enhanced resistance to infection in mice , 1993, Infection and immunity.

[96]  C. Hawrylowicz,et al.  Strategies for use of IL‐10 or its antagonists in human disease , 2008, Immunological reviews.

[97]  R. Coffman,et al.  Interleukin-10 and the interleukin-10 receptor. , 2001, Annual review of immunology.

[98]  A. Rudensky,et al.  Expansion and function of Foxp3-expressing T regulatory cells during tuberculosis , 2007, The Journal of experimental medicine.

[99]  Alan D. Roberts,et al.  The role of interleukin-12 in acquired immunity to Mycobacterium tuberculosis infection. , 1995, Immunology.

[100]  S. Ehlers,et al.  Granulocytes Accelerated and Enhanced Recruitment of Tuberculosis in Mice Causally Involves Genetically Determined Susceptibility To , 2022 .

[101]  S. Hickman,et al.  Mycobacterium tuberculosis Induces Differential Cytokine Production from Dendritic Cells and Macrophages with Divergent Effects on Naive T Cell Polarization1 , 2002, The Journal of Immunology.

[102]  V. Boussiotis,et al.  IL-10-producing T cells suppress immune responses in anergic tuberculosis patients. , 2000, The Journal of clinical investigation.

[103]  J. Flynn,et al.  Effects of aminoguanidine on latent murine tuberculosis. , 1998, Journal of immunology.

[104]  B. Bloom,et al.  Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages , 1992, The Journal of experimental medicine.

[105]  G. Bancroft,et al.  Enhanced protection to Mycobacterium tuberculosis infection in IL-10-deficient mice is accompanied by early and enhanced Th1 responses in the lung , 2010, European journal of immunology.

[106]  S. Holland Interferon gamma, IL-12, IL-12R and STAT-1 immunodeficiency diseases: disorders of the interface of innate and adaptive immunity , 2007, Immunologic research.

[107]  C. Demangel,et al.  Autocrine IL‐10 impairs dendritic cell (DC)‐derived immune responses to mycobacterial infection by suppressing DC trafficking to draining lymph nodes and local IL‐12 production , 2002, European journal of immunology.

[108]  David M Tobin,et al.  Comparative pathogenesis of Mycobacterium marinum and Mycobacterium tuberculosis , 2008, Cellular microbiology.

[109]  S. Gordon,et al.  Syk-dependent cytokine induction by Dectin-1 reveals a novel pattern recognition pathway for C type lectins. , 2005, Immunity.

[110]  A. Cooper,et al.  IL-17 and Th17 cells in tuberculosis. , 2010, Cytokine & growth factor reviews.

[111]  S. Dorman,et al.  A human IFNGR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection , 1999, Nature Genetics.

[112]  H. Mollenkopf,et al.  The adaptor molecule CARD9 is essential for tuberculosis control , 2010, The Journal of experimental medicine.

[113]  A. Sher,et al.  MyD88-Deficient Mice Display a Profound Loss in Resistance to Mycobacterium tuberculosis Associated with Partially Impaired Th1 Cytokine and Nitric Oxide Synthase 2 Expression , 2004, Infection and Immunity.

[114]  Bodo Grimbacher,et al.  STAT3 mutations in the hyper-IgE syndrome. , 2007, The New England journal of medicine.

[115]  David F. Richards,et al.  In Vitro Generation of Interleukin 10–producing Regulatory CD4+ T Cells Is Induced by Immunosuppressive Drugs and Inhibited by T Helper Type 1 (Th1)– and Th2-inducing Cytokines , 2002, The Journal of experimental medicine.

[116]  Y. Belkaid,et al.  Regulatory ripples , 2010, Nature Immunology.

[117]  J. Flynn,et al.  Reactivation of Latent Tuberculosis: Variations on the Cornell Murine Model , 1999, Infection and Immunity.

[118]  N. Juffermans,et al.  Serum concentrations of cytokines in patients with active tuberculosis (TB) and after treatment , 1999, Clinical and experimental immunology.

[119]  S. Dorman,et al.  Interferon-γ and interleukin-12 pathway defects and human disease , 2000 .

[120]  Genhong Cheng,et al.  Cutting Edge: Involvement of the Type I IFN Production and Signaling Pathway in Lipopolysaccharide-Induced IL-10 Production1 , 2007, The Journal of Immunology.

[121]  J. Casanova,et al.  Partial interferon-gamma receptor 1 deficiency in a child with tuberculoid bacillus Calmette-Guérin infection and a sibling with clinical tuberculosis. , 1997, The Journal of clinical investigation.

[122]  A. Crampin,et al.  Large-scale candidate gene study of tuberculosis susceptibility in the Karonga district of northern Malawi. , 2004, The American journal of tropical medicine and hygiene.

[123]  Y. Belkaid,et al.  The Role of Interleukin (IL)-10 in the Persistence of Leishmania major in the Skin after Healing and the Therapeutic Potential of Anti–IL-10 Receptor Antibody for Sterile Cure , 2001, The Journal of experimental medicine.

[124]  P. Ghazal,et al.  Hijacking and exploitation of IL-10 by intracellular pathogens. , 2001, Trends in microbiology.

[125]  R. Locksley,et al.  IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge , 2007, Nature Immunology.

[126]  JoAnne L. Flynn,et al.  Fate of Mycobacterium tuberculosis within Murine Dendritic Cells , 2001, Infection and Immunity.

[127]  J. Keane,et al.  IL-10 blocks phagosome maturation in mycobacterium tuberculosis-infected human macrophages. , 2011, American journal of respiratory cell and molecular biology.

[128]  T. Mosmann,et al.  IL-10 inhibits cytokine production by activated macrophages. , 1991, Journal of immunology.

[129]  S. Akira,et al.  MyD88 Primes Macrophages for Full-Scale Activation by Interferon-γ yet Mediates Few Responses to Mycobacterium tuberculosis , 2003, The Journal of experimental medicine.

[130]  H. Shin,et al.  Common interleukin 10 polymorphism associated with decreased risk of tuberculosis , 2005, Experimental & Molecular Medicine.

[131]  J. Delgado,et al.  Ethnic-specific genetic associations with pulmonary tuberculosis. , 2002, The Journal of infectious diseases.

[132]  R. Hernández-Pando,et al.  Airways infection with virulent Mycobacterium tuberculosis delays the influx of dendritic cells and the expression of costimulatory molecules in mediastinal lymph nodes , 2004, Immunology.

[133]  C. Leclerc,et al.  Coactivation of Syk kinase and MyD88 adaptor protein pathways by bacteria promotes regulatory properties of neutrophils. , 2009, Immunity.

[134]  J. Abrams,et al.  Cytokine production at the site of disease in human tuberculosis , 1993, Infection and immunity.

[135]  B. Foxwell,et al.  Signal Transducer and Activator of Transcription 3 Is the Dominant Mediator of the Anti-Inflammatory Effects of IL-10 in Human Macrophages , 2004, The Journal of Immunology.

[136]  M. Fei,et al.  IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia , 2008, Nature Medicine.

[137]  P. R. Narayanan,et al.  Interleukin-12B & interleukin-10 gene polymorphisms in pulmonary tuberculosis. , 2007, The Indian journal of medical research.

[138]  G. Kaplan,et al.  Hypervirulent M. tuberculosis W/Beijing strains upregulate type I IFNs and increase expression of negative regulators of the Jak-Stat pathway. , 2005, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[139]  F. Powrie,et al.  Regulatory T cells reinforce intestinal homeostasis. , 2009, Immunity.

[140]  K. Tanaka,et al.  Effects of nitric oxide synthase inhibitors on murine infection with Mycobacterium tuberculosis , 1995, Infection and immunity.

[141]  L. Ramakrishnan,et al.  The Role of the Granuloma in Expansion and Dissemination of Early Tuberculous Infection , 2009, Cell.

[142]  J. Casanova,et al.  Association of IL12RB1 polymorphisms with pulmonary tuberculosis in adults in Morocco. , 2004, The Journal of infectious diseases.

[143]  M. Quail,et al.  Tuberculous Granuloma Induction via Interaction of a Bacterial Secreted Protein with Host Epithelium , 2010, Science.

[144]  S. Akira,et al.  Microbial Recognition Via Toll-Like Receptor-Dependent and -Independent Pathways Determines the Cytokine Response of Murine Dendritic Cell Subsets to CD40 Triggering1 , 2002, The Journal of Immunology.

[145]  T. Mosmann,et al.  IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. , 1991, Journal of immunology.

[146]  J. Pedrosa,et al.  Pathological role of interleukin 17 in mice subjected to repeated BCG vaccination after infection with Mycobacterium tuberculosis , 2010, The Journal of experimental medicine.

[147]  G. Kaplan,et al.  Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-α/β , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[148]  D. McGavern,et al.  IL-10 blockade facilitates DNA vaccine-induced T cell responses and enhances clearance of persistent virus infection , 2008, The Journal of experimental medicine.

[149]  I. Orme,et al.  Lack of IL-10 alters inflammatory and immune responses during pulmonary Mycobacterium tuberculosis infection. , 2009, Tuberculosis.

[150]  D. Flaherty,et al.  Interleukin-10 Promotes Mycobacterium tuberculosis Disease Progression in CBA/J Mice1 , 2008, The Journal of Immunology.

[151]  T. Mosmann,et al.  Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones , 1989, The Journal of experimental medicine.

[152]  Frank Kaiser,et al.  TPL-2 negatively regulates interferon-β production in macrophages and myeloid dendritic cells , 2009, The Journal of experimental medicine.

[153]  Ching Li,et al.  A Defect in Interleukin-10 Leads to Enhanced Malarial Disease in Plasmodium chabaudi chabaudi Infection in Mice , 1999, Infection and Immunity.

[154]  B. Ryffel,et al.  Fatal Mycobacterium tuberculosis infection despite adaptive immune response in the absence of MyD88. , 2004, The Journal of clinical investigation.

[155]  K. Rajewsky,et al.  Interleukin-10-deficient mice develop chronic enterocolitis , 1993, Cell.

[156]  G. Kaplan,et al.  Arginine Usage in Mycobacteria-Infected Macrophages Depends on Autocrine-Paracrine Cytokine Signaling , 2010, Science Signaling.

[157]  John Chan,et al.  Depletion of Cd4+ T Cells Causes Reactivation of Murine Persistent Tuberculosis despite Continued Expression of Interferon γ and Nitric Oxide Synthase 2 , 2000, The Journal of experimental medicine.

[158]  S. Vermund,et al.  A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. , 1989, The New England journal of medicine.

[159]  U. Schaible,et al.  Mycobacterium‐containing phagosomes are accessible to early endosomes and reflect a transitional state in normal phagosome biogenesis. , 1996, The EMBO journal.

[160]  R. Appelberg,et al.  Blocking the Receptor for Interleukin 10 Protects Mice from Lethal Listeriosis , 2001, Antimicrobial Agents and Chemotherapy.

[161]  N. Boéchat,et al.  Down-modulation of lung immune responses by interleukin-10 and transforming growth factor beta (TGF-beta) and analysis of TGF-beta receptors I and II in active tuberculosis. , 2004, Infection and immunity.

[162]  L. Teyton,et al.  Interleukin-10 determines viral clearance or persistence in vivo , 2006, Nature Medicine.

[163]  T. Slifer,et al.  IL-10 is required to prevent immune hyperactivity during infection with Trypanosoma cruzi. , 1997, Journal of immunology.

[164]  A. Sher,et al.  IL-10 inhibits parasite killing and nitrogen oxide production by IFN-gamma-activated macrophages. , 1992, Journal of immunology.

[165]  J. Abastado,et al.  Constrained Intracellular Survival of Mycobacterium tuberculosis in Human Dendritic Cells 1 , 2003, The Journal of Immunology.

[166]  S. Nakae,et al.  Essential Role of IL-17A in the Formation of a Mycobacterial Infection-Induced Granuloma in the Lung , 2010, The Journal of Immunology.

[167]  M. Conde,et al.  TheMycobacterium tuberculosis Complex-Restricted Genecfp32 Encodes an Expressed Protein That Is Detectable inTuberculosis Patients and Is Positively Correlated with PulmonaryInterleukin-10 , 2003, Infection and Immunity.

[168]  Timothy J. Sturgeon,et al.  Reactivation of Latent Tuberculosis in Cynomolgus Macaques Infected with SIV Is Associated with Early Peripheral T Cell Depletion and Not Virus Load , 2010, PloS one.

[169]  A. Myers,et al.  Tumor necrosis factor neutralization results in disseminated disease in acute and latent Mycobacterium tuberculosis infection with normal granuloma structure in a cynomolgus macaque model. , 2010, Arthritis and rheumatism.

[170]  S. Kaufmann,et al.  Iron Chelation Via Deferoxamine Exacerbates Experimental Salmonellosis Via Inhibition of the Nicotinamide Adenine Dinucleotide Phosphate Oxidase-Dependent Respiratory Burst , 2002, The Journal of Immunology.

[171]  Alicia González,et al.  Interferon-γ and Interleukin-10 Gene Polymorphisms in Pulmonary Tuberculosis , 2003 .

[172]  S. Fortune,et al.  Variation among Genome Sequences of H37Rv Strains of Mycobacterium tuberculosis from Multiple Laboratories , 2010, Journal of bacteriology.

[173]  Y. Belkaid,et al.  Conditions Influencing the Efficacy of Vaccination with Live Organisms against Leishmania major Infection , 2005, Infection and Immunity.

[174]  H. Oral,et al.  Interleukin-10 (IL-10) gene polymorphism as a potential host susceptibility factor in tuberculosis. , 2006, Cytokine.